Literature DB >> 17416740

Proinflammatory response of alveolar epithelial cells is enhanced by alveolar macrophage-produced TNF-alpha during pulmonary ischemia-reperfusion injury.

Ashish K Sharma1, Lucas G Fernandez, Alaa S Awad, Irving L Kron, Victor E Laubach.   

Abstract

Pulmonary ischemia-reperfusion (IR) injury entails acute activation of alveolar macrophages followed by neutrophil sequestration. Although proinflammatory cytokines and chemokines such as TNF-alpha and monocyte chemoattractant protein-1 (MCP-1) from macrophages are known to modulate acute IR injury, the contribution of alveolar epithelial cells to IR injury and their intercellular interactions with other cell types such as alveolar macrophages and neutrophils remain unclear. In this study, we tested the hypothesis that following IR, alveolar macrophage-produced TNF-alpha further induces alveolar epithelial cells to produce key chemokines that could then contribute to subsequent lung injury through the recruitment of neutrophils. Cultured RAW264.7 macrophages and MLE-12 alveolar epithelial cells were subjected to acute hypoxia-reoxygenation (H/R) as an in vitro model of pulmonary IR. H/R (3 h/1 h) significantly induced KC, MCP-1, macrophage inflammatory protein-2 (MIP-2), RANTES, and IL-6 (but not TNF-alpha) by MLE-12 cells, whereas H/R induced TNF-alpha, MCP-1, RANTES, MIP-1alpha, and MIP-2 (but not KC) by RAW264.7 cells. These results were confirmed using primary murine alveolar macrophages and primary alveolar type II cells. Importantly, using macrophage and epithelial coculture methods, the specific production of TNF-alpha by H/R-exposed RAW264.7 cells significantly induced proinflammatory cytokine/chemokine expression (KC, MCP-1, MIP-2, RANTES, and IL-6) by MLE-12 cells. Collectively, these results demonstrate that alveolar type II cells, in conjunction with alveolar macrophage-produced TNF-alpha, contribute to the initiation of acute pulmonary IR injury via a proinflammatory cascade. The release of key chemokines, such as KC and MIP-2, by activated type II cells may thus significantly contribute to neutrophil sequestration during IR injury.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17416740     DOI: 10.1152/ajplung.00470.2006

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  55 in total

1.  Tumor necrosis factor-alpha from macrophages enhances LPS-induced clara cell expression of keratinocyte-derived chemokine.

Authors:  Arnon Elizur; Tracy L Adair-Kirk; Diane G Kelley; Gail L Griffin; Daphne E Demello; Robert M Senior
Journal:  Am J Respir Cell Mol Biol       Date:  2007-08-02       Impact factor: 6.914

2.  Activation of sphingosine-1-phosphate 1 receptor in the proximal tubule protects against ischemia-reperfusion injury.

Authors:  Amandeep Bajwa; Sang-Kyung Jo; Hong Ye; Liping Huang; Krishna R Dondeti; Diane L Rosin; Volker H Haase; Timothy L Macdonald; Kevin R Lynch; Mark D Okusa
Journal:  J Am Soc Nephrol       Date:  2010-03-25       Impact factor: 10.121

3.  Moderate oxygen augments lipopolysaccharide-induced lung injury in mice.

Authors:  Neil R Aggarwal; Franco R D'Alessio; Kenji Tsushima; D Clark Files; Mahendra Damarla; Venkataramana K Sidhaye; Mostafa M Fraig; Vsevolod Y Polotsky; Landon S King
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-12-24       Impact factor: 5.464

Review 4.  Models of Lung Transplant Research: a consensus statement from the National Heart, Lung, and Blood Institute workshop.

Authors:  Vibha N Lama; John A Belperio; Jason D Christie; Souheil El-Chemaly; Michael C Fishbein; Andrew E Gelman; Wayne W Hancock; Shaf Keshavjee; Daniel Kreisel; Victor E Laubach; Mark R Looney; John F McDyer; Thalachallour Mohanakumar; Rebecca A Shilling; Angela Panoskaltsis-Mortari; David S Wilkes; Jerry P Eu; Mark R Nicolls
Journal:  JCI Insight       Date:  2017-05-04

5.  Alveolar epithelial cells are critical in protection of the respiratory tract by secretion of factors able to modulate the activity of pulmonary macrophages and directly control bacterial growth.

Authors:  Olga D Chuquimia; Dagbjort H Petursdottir; Natalia Periolo; Carmen Fernández
Journal:  Infect Immun       Date:  2012-11-12       Impact factor: 3.441

6.  Adenosine A3 receptor activation attenuates lung ischemia-reperfusion injury.

Authors:  Daniel P Mulloy; Ashish K Sharma; Lucas G Fernandez; Yunge Zhao; Christine L Lau; Irving L Kron; Victor E Laubach
Journal:  Ann Thorac Surg       Date:  2013-03-28       Impact factor: 4.330

7.  Adenosine A2A receptor activation on CD4+ T lymphocytes and neutrophils attenuates lung ischemia-reperfusion injury.

Authors:  Ashish K Sharma; Victor E Laubach; Susan I Ramos; Yunge Zhao; George Stukenborg; Joel Linden; Irving L Kron; Zequan Yang
Journal:  J Thorac Cardiovasc Surg       Date:  2009-11-11       Impact factor: 5.209

Review 8.  Innate immunity and organ transplantation: focus on lung transplantation.

Authors:  Daniel Kreisel; Daniel R Goldstein
Journal:  Transpl Int       Date:  2012-08-21       Impact factor: 3.782

9.  A systematic molecular pathology study of a laboratory confirmed H5N1 human case.

Authors:  Rongbao Gao; Libo Dong; Jie Dong; Leying Wen; Ye Zhang; Hongjie Yu; Zijian Feng; Minmei Chen; Yi Tan; Zhaojun Mo; Haiyan Liu; Yunyan Fan; Kunxiong Li; Chris Ka-Fai Li; Dexin Li; Weizhong Yang; Yuelong Shu
Journal:  PLoS One       Date:  2010-10-12       Impact factor: 3.240

10.  Protection from pulmonary ischemia-reperfusion injury by adenosine A2A receptor activation.

Authors:  Ashish K Sharma; Joel Linden; Irving L Kron; Victor E Laubach
Journal:  Respir Res       Date:  2009-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.